1 completed, 1 withdrawn. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
Follow HSPPC-96: new trials by email Literature Review of HSPPC-96 trials Research Report on HSPPC-96
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Study to Evaluate the Effects of a Vaccine (HSPPC-96) Combined With Ipilimumab in Patients With Advanced Melanoma ipilimumab, HSPPC-96 - Melanoma | Phase 1 / Phase 2 | Withdrawn | Rabih Said | 2015-12-01 | 2016-01-25 | |
| GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma HSPPC-96, Standard Surgical Resection - Brain and Central Nervous System Tumors | Phase 1 / Phase 2 | Completed | University of California, San Francisco | 96 | 2005-11-18 | 2021-05-13 |
Brain Neoplasms (1) · Central Nervous System Neoplasms (1) · Glioblastoma (1) · Melanoma (1)
Rabih Said (1) · University of California, San Francisco (1)
United States (2)
Jennifer Clarke, MD (1) · Rabih Said, MD, MPH (1)
P50CA097257 (1), R01CA164714 (1)